NCT06713226View on ClinicalTrials.gov

Clinical Performance Evaluation of the Hativ P30

NANot yet recruitingINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

July 23, 2025

Study Completion Date

July 23, 2025

Conditions

Arrhythmia

Interventions

DEVICE

Hativ P30 and 12-lead ECG comparator device

"The purpose of this study is to compare the clinical equivalence and diagnostic ability of the Hativ P30 against the 12-lead ECG comparator device.~Electrocardiograms of all participants will be obtained using both the Hativ P30 and a 12-lead ECG comparator. That is, all participants will get the same intervention."

All Listed Sponsors

lead

VUNO Inc.

INDUSTRY

NCT06713226 - Clinical Performance Evaluation of the Hativ P30 | Biotech Hunter | Biotech Hunter